Centene Corporation announced the retirement of Kenneth A. Burdick from its Board of Directors, effective July 28, 2026, and the appointment of Paul J. Diaz to the Board on the same date. Burdick, who joined in 2022, brought extensive healthcare leadership experience, including roles as EVP at Centene and CEO of WellCare Health Plans. Diaz, a managing partner at Cressey & Company and former CEO of Myriad Genetics and Kindred Healthcare, brings strong healthcare industry and public company board expertise. This leadership change supports Centene's ongoing strategy to improve healthcare access and quality for its members.
Centene reported a net income of $1.09 billion in Q2 2026, reversing a $253 million loss from the previous year, driven by better control of rising medical costs and a lower health benefits ratio of 89.6%. Despite a sharp drop in Obamacare marketplac...
Canada Nickel Company has extended the repayment date of its $32 million loan from Auramet International from August 9, 2026, to November 9, 2026. The extension includes a fee of $856,288 and the issuance of 5.5 million share purchase warrants to Aur...
